Scholars Central

Mini reviewPublished 28 Apr 2022

Hematologic malignancies in covid 19

Authors: Jennie Reed

Journal of Cancer & Metastasis Research

Volume 4 · Issue 2 · Pages 1–3

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Heart Review partner investigation of patient electronic wellbeing records of 514,413 completely inoculated patients from 63 medical care associations in the US, incorporating 5956 with HM and 508,457 without malignancies during the period from December 2020 to October 2021. The advancement SARS-CoV-2 contaminations in patients with HM consistently expanded and arrived at 67.7 cases per 1000 people in October 2020 The general mortality hazard was 5.7% for patients with HM who had forward leap diseases, altogether higher than the 0.8% for the people who had no advancement contaminations (HR: 10.25, 95% CI:5.94-17.69. In the US, three COVID-19 immunizations have been approved since December 2020.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Journal of Cancer & Metastasis Research.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Cancer & Metastasis Research
  • SubjectOncology & Cancer
  • BylineArticles whose byline prints “Jennie Reed”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels